Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70-111 Szczecin, Poland.
Department of Histology and Embryology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Int J Mol Sci. 2023 Jan 9;24(2):1260. doi: 10.3390/ijms24021260.
The intestinal microflora is extremely important, not only in the processes of absorption, digestion and biosynthesis of vitamins, but also in shaping the immune and cognitive functions of the human body. Several studies demonstrate a correlation between microbiota composition and such events as graft rejection, kidney interstitial fibrosis, urinary tract infections, and diarrhoea or graft tolerance. Some of those changes might be directly linked with pathologies such as colonization with pathogenic bacterial strains. Gut microbiota composition also plays an important role in metabolic complications and viral infections after transplantation. From the other side, gut microbiota might induce graft tolerance by promotion of T and B regulatory cells. Graft tolerance induction is still an extremely important issue regarding transplantology and might allow the reduction or even avoidance of immunosuppressive treatment. Although there is a rising evidence of the pivotal role of gut microbiota in aspects of kidney transplantation there is still a lack of knowledge on the direct mechanisms of microbiota action. Furthermore, some of those negative effects could be reversed by probiotics of faecal microbiota trapoinsplantation. While diabetes and hypertension as well as BKV and CMV viremia are common and important complications of transplantation, both worsening the graft function and causing systemic injuries, it opens up potential clinical treatment options. As has been also suggested in the current review, some bacterial subsets exhibit protective properties. However, currently, there is a lack of evidence on pro- and prebiotic supplementation in kidney transplant patients. In the current review, we describe the effect of the microbiota on the transplanted kidney in renal transplant recipients.
肠道微生物群极为重要,不仅在维生素的吸收、消化和生物合成过程中发挥作用,而且在塑造人体的免疫和认知功能方面也发挥着重要作用。有几项研究表明,微生物群组成与移植物排斥、肾间质纤维化、尿路感染、腹泻或移植物耐受等事件之间存在相关性。其中一些变化可能与定植的致病性细菌菌株等病理学直接相关。肠道微生物群组成在移植后代谢并发症和病毒感染中也起着重要作用。另一方面,肠道微生物群可能通过促进 T 和 B 调节细胞来诱导移植物耐受。诱导移植物耐受仍然是移植学中一个极其重要的问题,它可能减少甚至避免免疫抑制治疗。尽管越来越多的证据表明肠道微生物群在肾脏移植方面起着关键作用,但对于微生物群作用的直接机制仍知之甚少。此外,一些负面效应可以通过粪便微生物群移植来逆转。尽管糖尿病和高血压以及 BKV 和 CMV 病毒血症是移植的常见且重要的并发症,它们会恶化移植物功能并导致全身损伤,但这为潜在的临床治疗选择提供了机会。正如本综述中所建议的,一些细菌亚群具有保护特性。然而,目前在肾脏移植患者中补充益生菌和益生元的证据不足。在本综述中,我们描述了微生物群对接受肾移植患者移植肾脏的影响。